作者
Claus Cursiefen, Lu Chen, Leonardo P Borges, David Jackson, Jingtai Cao, Czeslaw Radziejewski, Patricia A D’Amore, M Reza Dana, Stanley J Wiegand, J Wayne Streilein
发表日期
2004/4/1
期刊
The Journal of clinical investigation
卷号
113
期号
7
页码范围
1040-1050
出版商
American Society for Clinical Investigation
简介
Lymphangiogenesis, an important initial step in tumor metastasis and transplant sensitization, is mediated by the action of VEGF-C and -D on VEGFR3. In contrast, VEGF-A binds VEGFR1 and VEGFR2 and is an essential hemangiogenic factor. We re-evaluated the potential role of VEGF-A in lymphangiogenesis using a novel model in which both lymphangiogenesis and hemangiogenesis are induced in the normally avascular cornea. Administration of VEGF Trap, a receptor-based fusion protein that binds and neutralizes VEGF-A but not VEGF-C or -D, completely inhibited both hemangiogenesis and the outgrowth of LYVE-1+ lymphatic vessels following injury. Furthermore, both lymphangiogenesis and hemangiogenesis were significantly reduced in mice transgenic for VEGF-A164/164 or VEGF-A188/188 (each of which expresses only one of the three principle VEGF-A isoforms). Because VEGF-A is chemotactic …
引用总数
200420052006200720082009201020112012201320142015201620172018201920202021202220232024114172587184867876799251666141565250483931
学术搜索中的文章